OUR PIPELINE
Building the technology to power the future of cancer care
We're building a suite of technologies to enable a new future for cancer care: from supportive care to enabling at-home cancer care at scale. Learn more about our technology pipeline and rollout below.
Enabling home infusion at scale
Enabling home infusion at scale
Enabling home infusion at scale
Reducing the side effects of cancer care
Preventing hair loss
Preventing hair loss
LOTUS
INFUSION
SET
Lotus Infusion Set
Making home infusion possible at scale.
The Lotus technology program aims to enable low-risk cancer treatment infusions at home. The Lotus Infusion Set is a device that allows patients and caregivers to gain IV access via a previously implanted port.
Simplifying the IV access process
The Lotus Infusion Set is designed to enable access to a subcutaneous port without placing a needle by hand.
Designed for patients and caregivers
The Lotus Infusion Set has in-built safety features that allow patients and caregivers to obtain IV access through a port.
Suitable for use in the home
A comprehensive support kit provides everything needed to obtain IV access at home.
Supports patient-led infusions
By enabling IV access to be done at-home, the Lotus Infusion Set creates an opportunity to deliver home infusions at scale.
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 35 40" xmlns="http://www.w3.org/2000/svg"><path d="M 10.898 30.794 C 7.314 31.947 3.428 31.723 0 30.166 C 0.37 26.374 2.156 22.862 5.002 20.329 L 5.064 20.381 C 5.745 20.949 6.473 21.458 7.24 21.902 C 8.47 22.609 9.79 23.146 11.165 23.497 C 10.781 24.872 10.586 26.281 10.586 27.692 C 10.587 28.713 10.687 29.731 10.885 30.732 Z M 23.291 31.103 L 23.351 31.125 C 22.518 34.707 20.408 37.862 17.416 40 C 14.425 37.861 12.315 34.706 11.481 31.125 L 11.541 31.103 C 12.421 30.786 13.272 30.391 14.073 29.929 C 15.3 29.218 16.425 28.343 17.416 27.329 C 19.066 29.014 21.075 30.305 23.294 31.103 Z M 29.83 20.331 L 29.828 20.332 C 29.828 20.332 29.827 20.331 29.827 20.331 Z M 29.828 20.332 C 32.675 22.864 34.462 26.377 34.832 30.168 C 31.464 31.696 27.576 31.973 23.934 30.796 L 23.946 30.735 C 24.144 29.725 24.246 28.705 24.246 27.695 C 24.246 26.283 24.05 24.874 23.667 23.499 C 25.042 23.148 26.362 22.612 27.591 21.904 C 28.358 21.46 29.086 20.951 29.767 20.383 Z M 23.939 9.206 C 27.523 8.052 31.409 8.276 34.837 9.834 C 34.466 13.626 32.679 17.139 29.832 19.671 L 29.77 19.619 C 29.078 19.043 28.346 18.531 27.594 18.098 C 26.37 17.393 25.052 16.86 23.669 16.503 C 24.053 15.128 24.249 13.719 24.249 12.308 C 24.247 11.287 24.147 10.269 23.949 9.268 L 23.937 9.206 Z M 11.544 8.897 L 11.484 8.875 C 12.317 5.293 14.427 2.138 17.419 0 C 20.41 2.139 22.52 5.294 23.354 8.875 L 23.294 8.897 C 22.417 9.213 21.569 9.606 20.762 10.072 C 19.535 10.782 18.41 11.656 17.419 12.67 C 15.769 10.985 13.76 9.695 11.541 8.897 Z M 5.065 19.619 L 5.067 19.619 L 5.005 19.671 C 2.157 17.14 0.37 13.626 0 9.834 C 3.428 8.277 7.314 8.053 10.898 9.206 L 10.886 9.268 C 10.687 10.277 10.586 11.298 10.586 12.307 C 10.588 13.725 10.782 15.137 11.165 16.503 C 9.79 16.853 8.47 17.39 7.24 18.098 C 6.474 18.543 5.746 19.052 5.065 19.619 Z" fill="rgb(198, 188, 244)" height="40.00000047302247px" id="FhfknWWzM" width="34.83700062561036px"/></svg>)
Timeline
We're building towards a future where patients can self-administer oncology medications in the home safely and at scale. Our Lotus Infusion Set development process is designed to gradually bring products to market that enable at-home cancer care for more patients.
Now
HORIZON: a feasibility study of patient self-infusion of oncology drugs using the Lotus Infusion Set.
Next
Anticipated FDA clearance to market and commercial availability in late 2026.
Future
Expanding the cohort of patients who are eligible for home treatment using novel monitoring technologies.
LOTUS
INFUSION
SET
Lotus Infusion Set
Making home infusion possible at scale.
The Lotus technology program aims to enable low-risk cancer treatment infusions at home. The Lotus Infusion Set is a device that allows patients and caregivers to gain IV access via a previously implanted port.
Simplifying the IV access process
The Lotus Infusion Set is designed to enable access to a subcutaneous port without placing a needle by hand.
Designed for patients and caregivers
The Lotus Infusion Set has in-built safety features that allow patients and caregivers to obtain IV access through a port.
Suitable for use in the home
A comprehensive support kit provides everything needed to obtain IV access at home.
Supports patient-led infusions
By enabling IV access to be done at-home, the Lotus Infusion Set creates an opportunity to deliver home infusions at scale.
Timeline
We're building towards a future where patients can self-administer oncology medications in the home safely and at scale. Our Lotus Infusion Set development process is designed to gradually bring products to market that enable at-home cancer care for more patients.
Now
HORIZON: a feasibility study of patient self-infusion of oncology drugs using the Lotus Infusion Set.
Next
Anticipated FDA clearance to market and commercial availability in late 2026.
Future
Expanding the cohort of patients who are eligible for home treatment using novel monitoring technologies.
LOTUS
INFUSION
SET
Lotus Infusion Set
Making home infusion possible at scale.
The Lotus technology program aims to enable low-risk cancer treatment infusions at home. The Lotus Infusion Set is a device that allows patients and caregivers to gain IV access via a previously implanted port.
Simplifying the IV access process
The Lotus Infusion Set is designed to enable access to a subcutaneous port without placing a needle by hand.
Designed for patients and caregivers
The Lotus Infusion Set has in-built safety features that allow patients and caregivers to obtain IV access through a port.
Suitable for use in the home
A comprehensive support kit provides everything needed to obtain IV access at home.
Supports patient-led infusions
By enabling IV access to be done at-home, the Lotus Infusion Set creates an opportunity to deliver home infusions at scale.
Timeline
We're building towards a future where patients can self-administer oncology medications in the home safely and at scale. Our Lotus Infusion Set development process is designed to gradually bring products to market that enable at-home cancer care for more patients.
Now
HORIZON: a feasibility study of patient self-infusion of oncology drugs using the Lotus Infusion Set.
Next
Anticipated FDA clearance to market and commercial availability in late 2026.
Future
Expanding the cohort of patients who are eligible for home treatment using novel monitoring technologies.
LOTUS
INFUSION
SET
Lotus Infusion Set
Making home infusion possible at scale.
Simplifying the IV access process
The Lotus Infusion Set is designed to enable access to a subcutaneous port without placing a needle by hand.
Designed for patients and caregivers
The Lotus Infusion Set has in-built safety features that allow patients and caregivers to obtain IV access through a port.
Suitable for use in the home
A comprehensive support kit provides everything needed to obtain IV access at home.
Supports patient-led infusions
By enabling IV access to be done at-home, the Lotus Infusion Set creates an opportunity to deliver home infusions at scale.
Timeline
We're building towards a future where patients can self-administer oncology medications in the home safely and at scale. Our Lotus Infusion Set development process is designed to gradually bring products to market that enable at-home cancer care for more patients.
Now
HORIZON: a feasibility study of patient self-infusion of oncology drugs using the Lotus Infusion Set.
Next
Anticipated FDA clearance to market and commercial availability in late 2026.
Future
Expanding the cohort of patients who are eligible for home treatment using novel monitoring technologies.
LILAC
Lilac
Reducing neuropathy caused by cancer drugs
Lilac is designed to reduce the amount of cytotoxic drug absorbed into the peripheral nerve structures of the hands and feet during cancer treatment - a leading cause of treatment discontinuation and dose reduction in chemotherapy treatment.
Aims to prevent neuropathy
Lilac is a pair of gloves and boots used at each chemotherapy session to prevent neuropathy before symptoms show.
No additional chair time
Lilac is portable and wearable - meaning patients can continue treatment outside of the infusion chair.
Avoids cold-related discomfort
Lilac uses an entirely non-cooling method to avoid cold-related pain associated with neuropathy prevention techniques.
Easy to use
Lilac comes in a one-size-fits-all garment that can be easily applied right before chemotherapy treatment.
Timeline
We're continuing to develop our neuropathy research to reach more drug indications and build a broader base of evidence for non-cooling approaches to neuropathy prevention.
Now
IMPACT pivotal clinical trial is currently underway in multiple sites across the US and Ireland.
Next
Submission to FDA for approval for patients receiving platinum and taxane chemotherapies.
Future
Expansion to prevention of neuropathy in ADCs containing MMAE payloads.
LILAC
Lilac
Reducing neuropathy caused by cancer drugs
Lilac is designed to reduce the amount of cytotoxic drug absorbed into the peripheral nerve structures of the hands and feet during cancer treatment - a leading cause of treatment discontinuation and dose reduction in chemotherapy treatment.
Aims to prevent neuropathy
Lilac is a pair of gloves and boots used at each chemotherapy session to prevent neuropathy before symptoms show.
No additional chair time
Lilac is portable and wearable - meaning patients can continue treatment outside of the infusion chair.
Avoids cold-related discomfort
Lilac uses an entirely non-cooling method to avoid cold-related pain associated with neuropathy prevention techniques.
Easy to use
Lilac comes in a one-size-fits-all garment that can be easily applied right before chemotherapy treatment.
Timeline
We're continuing to develop our neuropathy research to reach more drug indications and build a broader base of evidence for non-cooling approaches to neuropathy prevention.
Now
IMPACT pivotal clinical trial is currently underway in multiple sites across the US and Ireland.
Next
Submission to FDA for approval for patients receiving platinum and taxane chemotherapies.
Future
Expansion to prevention of neuropathy in ADCs containing MMAE payloads.
LILAC
Lilac
Reducing neuropathy caused by cancer drugs
Lilac is designed to reduce the amount of cytotoxic drug absorbed into the peripheral nerve structures of the hands and feet during cancer treatment - a leading cause of treatment discontinuation and dose reduction in chemotherapy treatment.
Aims to prevent neuropathy
Lilac is a pair of gloves and boots used at each chemotherapy session to prevent neuropathy before symptoms show.
No additional chair time
Lilac is portable and wearable - meaning patients can continue treatment outside of the infusion chair.
Avoids cold-related discomfort
Lilac uses an entirely non-cooling method to avoid cold-related pain associated with neuropathy prevention techniques.
Easy to use
Lilac comes in a one-size-fits-all garment that can be easily applied right before chemotherapy treatment.
Timeline
We're continuing to develop our neuropathy research to reach more drug indications and build a broader base of evidence for non-cooling approaches to neuropathy prevention.
Now
IMPACT pivotal clinical trial is currently underway in multiple sites across the US and Ireland.
Next
Submission to FDA for approval for patients receiving platinum and taxane chemotherapies.
Future
Expansion to prevention of neuropathy in ADCs containing MMAE payloads.
LILAC
Lilac
Reducing neuropathy caused by cancer drugs
Aims to prevent neuropathy
Lilac is a pair of gloves and boots used at each chemotherapy session to prevent neuropathy before symptoms show.
No additional chair time
Lilac is portable and wearable - meaning patients can continue treatment outside of the infusion chair.
Avoids cold-related discomfort
Lilac uses an entirely non-cooling method to avoid cold-related pain associated with neuropathy prevention techniques.
Easy to use
Lilac comes in a one-size-fits-all garment that can be easily applied right before chemotherapy treatment.
Timeline
We're continuing to develop our neuropathy research to reach more drug indications and build a broader base of evidence for non-cooling approaches to neuropathy prevention.
Now
IMPACT pivotal clinical trial is currently underway in multiple sites across the US and Ireland.
Next
Submission to FDA for approval for patients receiving platinum and taxane chemotherapies.
Future
Expansion to prevention of neuropathy in ADCs containing MMAE payloads.
LILY
Lily
Preventing hair loss caused by chemotherapy.
Lily is designed to help reduce chemotherapy related hair loss - supporting patients through one of treatment’s most visible and emotional side effects.
Portable, wearable device
Lily is a wearable headset device that's entirely portable - meaning patients aren't stuck in an infusion chair.
Designed for patient use
Paired with a simple control panel, Lily is designed for easy use by a patient, caregiver, or healthcare professional.
Comfortable, non-cooling therapy
Lily uses a non-cooling therapeutic approach that avoids cold-related pain on the scalp.
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><g d="M 3.852 18.551 C 3.653 18.533 3.5 18.367 3.5 18.167 C 3.5 17.966 3.653 17.8 3.852 17.782 C 5.48 17.687 7.109 17.617 8.738 17.577 C 8.731 16.684 8.721 15.218 8.714 13.541 C 6.444 13.526 4.519 13.519 4.204 13.536 C 4 13.546 3.824 13.395 3.801 13.193 C 3.779 12.99 3.919 12.804 4.12 12.77 C 4.97 12.628 6.69 12.496 8.71 12.416 C 8.706 11.109 8.704 9.732 8.704 8.429 C 7.564 8.394 7.239 8.373 6.884 8.349 C 6.475 8.324 6.025 8.295 4.238 8.239 C 4.033 8.233 3.87 8.067 3.866 7.862 C 3.863 7.657 4.021 7.485 4.225 7.472 C 5.717 7.357 7.211 7.283 8.707 7.252 C 8.714 5.295 8.731 3.644 8.767 2.882 C 8.768 2.67 8.939 2.499 9.151 2.5 C 9.363 2.501 9.534 2.672 9.533 2.884 C 9.651 4.333 9.746 5.784 9.817 7.236 C 11.494 7.223 13.17 7.263 14.844 7.356 C 14.821 4.953 14.804 3.052 14.804 2.959 C 14.798 2.745 14.968 2.567 15.182 2.561 C 15.396 2.555 15.574 2.725 15.58 2.939 C 15.76 4.432 15.904 5.929 16.009 7.429 C 17.385 7.525 18.759 7.657 20.128 7.825 C 20.337 7.854 20.488 8.04 20.475 8.25 C 20.462 8.461 20.289 8.626 20.078 8.629 C 19.425 8.618 18.05 8.601 16.623 8.584 L 16.083 8.577 C 16.157 9.852 16.205 11.127 16.225 12.404 C 18.778 12.526 20.678 12.816 20.618 13.364 C 20.577 13.749 20.43 13.742 19.107 13.687 C 18.406 13.657 17.705 13.634 17.004 13.62 L 16.236 13.61 C 16.239 14.935 16.214 16.259 16.159 17.583 C 17.627 17.622 19.093 17.683 20.559 17.767 C 20.774 17.778 20.943 17.955 20.943 18.171 C 20.943 18.386 20.774 18.563 20.559 18.574 C 19.075 18.66 17.589 18.721 16.104 18.761 L 16.094 18.919 C 16.073 19.908 16.066 20.676 16.06 21.272 C 16.041 23.254 16.04 23.329 15.629 23.342 C 15.139 23.359 15.07 22.896 14.972 18.786 C 14.318 18.798 13.665 18.805 13.012 18.808 C 13.317 20.35 13.287 21.941 12.917 23.471 C 12.915 23.574 12.873 23.672 12.799 23.743 C 12.686 23.85 12.519 23.88 12.376 23.818 C 12.233 23.756 12.14 23.614 12.141 23.458 C 11.883 21.919 11.869 20.351 12.099 18.809 C 11.362 18.807 10.624 18.8 9.886 18.787 L 9.876 19.042 C 9.852 20.16 9.847 20.995 9.844 21.62 C 9.833 23.393 9.832 23.466 9.432 23.486 C 8.902 23.511 8.87 22.91 8.756 18.761 C 7.121 18.721 5.485 18.65 3.851 18.551 Z M 9.977 13.551 C 9.98 14.885 9.963 16.219 9.927 17.553 C 11.599 17.525 13.27 17.526 14.942 17.556 L 14.903 13.596 C 13.261 13.579 11.619 13.564 9.977 13.551 Z M 14.891 12.356 L 14.855 8.562 C 14.008 8.552 13.16 8.54 12.313 8.524 L 9.87 8.463 C 9.922 9.766 9.955 11.069 9.97 12.373 C 11.61 12.325 13.251 12.319 14.891 12.356 Z M 4.522 3.23 C 5.78 1.997 8.155 1.905 12.588 2.095 C 12.578 1.405 12.711 0.729 13.67 0.333 C 15.282 -0.02 16.943 -0.093 18.58 0.117 C 20.297 0.526 20.476 1.954 20.416 3.582 C 21.5 5.276 21.393 9.338 21.127 19.39 L 21.038 22.8 C 21.912 22.818 22.633 22.843 23.142 22.875 C 23.358 22.889 23.524 23.071 23.518 23.288 C 23.513 23.504 23.338 23.678 23.122 23.682 C 15.546 24.112 7.952 24.106 0.378 23.664 C 0.167 23.661 -0.003 23.487 0 23.276 C 0.003 23.064 0.177 22.895 0.388 22.898 L 3.2 22.858 C 3.272 19.083 3.228 15.974 3.192 13.418 C 3.109 7.608 3.068 4.656 4.522 3.23 Z M 3.976 22.85 C 8.4 22.795 15.766 22.723 20.216 22.787 C 20.216 22.097 20.214 21.433 20.213 20.792 C 20.198 7.702 20.193 4.582 18.847 3.812 C 18.425 3.572 17.872 3.561 17.147 3.547 C 16.91 3.543 16.657 3.537 16.382 3.525 C 15.458 3.478 14.534 3.429 13.61 3.375 C 9.023 3.118 6.69 2.985 5.495 4.089 C 4.258 5.23 4.243 7.697 4.213 12.716 C 4.197 15.338 4.177 18.658 3.976 22.85 Z M 16.445 2.283 C 17.738 2.343 18.705 2.401 19.42 2.723 C 19.39 2.568 19.346 2.407 19.29 2.24 C 18.93 1.18 18.187 1.202 16.165 1.26 C 15.76 1.27 15.304 1.284 14.789 1.29 C 13.718 1.32 13.538 1.531 13.451 2.132 C 14.075 2.162 14.738 2.196 15.438 2.232 Z" fill="transparent" height="23.999720020808233px" id="vtebm2xKf" width="23.51861246879796px"><path d="M 0.352 16.051 C 0.153 16.033 0 15.867 0 15.667 C 0 15.466 0.153 15.3 0.352 15.282 C 1.98 15.187 3.609 15.117 5.238 15.077 C 5.231 14.184 5.221 12.718 5.214 11.041 C 2.944 11.026 1.019 11.019 0.704 11.036 C 0.5 11.046 0.324 10.895 0.301 10.693 C 0.279 10.49 0.419 10.304 0.62 10.27 C 1.47 10.128 3.19 9.996 5.21 9.916 C 5.206 8.609 5.204 7.232 5.204 5.929 C 4.064 5.894 3.739 5.873 3.384 5.849 C 2.975 5.824 2.525 5.795 0.738 5.739 C 0.533 5.733 0.37 5.567 0.366 5.362 C 0.363 5.157 0.521 4.985 0.725 4.972 C 2.217 4.857 3.711 4.783 5.207 4.752 C 5.214 2.795 5.231 1.144 5.267 0.382 C 5.268 0.17 5.439 -0.001 5.651 0 C 5.863 0.001 6.034 0.172 6.033 0.384 C 6.151 1.833 6.246 3.284 6.317 4.736 C 7.994 4.723 9.67 4.763 11.344 4.856 C 11.321 2.453 11.304 0.552 11.304 0.459 C 11.298 0.245 11.468 0.067 11.682 0.061 C 11.896 0.055 12.074 0.225 12.08 0.439 C 12.26 1.932 12.404 3.429 12.509 4.929 C 13.885 5.025 15.259 5.157 16.628 5.325 C 16.837 5.354 16.988 5.54 16.975 5.75 C 16.962 5.961 16.789 6.126 16.578 6.129 C 15.925 6.118 14.55 6.101 13.123 6.084 L 12.583 6.077 C 12.657 7.352 12.705 8.627 12.725 9.904 C 15.278 10.026 17.178 10.316 17.118 10.864 C 17.077 11.249 16.93 11.242 15.607 11.187 C 14.906 11.157 14.205 11.134 13.504 11.12 L 12.736 11.11 C 12.739 12.435 12.714 13.759 12.659 15.083 C 14.127 15.122 15.593 15.183 17.059 15.267 C 17.274 15.278 17.443 15.455 17.443 15.671 C 17.443 15.886 17.274 16.063 17.059 16.074 C 15.575 16.16 14.089 16.221 12.604 16.261 L 12.594 16.419 C 12.573 17.408 12.566 18.176 12.56 18.772 C 12.541 20.754 12.54 20.829 12.129 20.842 C 11.639 20.859 11.57 20.396 11.472 16.286 C 10.818 16.298 10.165 16.305 9.512 16.308 C 9.817 17.85 9.787 19.441 9.417 20.971 C 9.415 21.074 9.373 21.172 9.299 21.243 C 9.186 21.35 9.019 21.38 8.876 21.318 C 8.733 21.256 8.64 21.114 8.641 20.958 C 8.383 19.419 8.369 17.851 8.599 16.309 C 7.862 16.307 7.124 16.3 6.386 16.287 L 6.376 16.542 C 6.352 17.66 6.347 18.495 6.344 19.12 C 6.333 20.893 6.332 20.966 5.932 20.986 C 5.402 21.011 5.37 20.41 5.256 16.261 C 3.621 16.221 1.985 16.15 0.351 16.051 Z M 6.477 11.051 C 6.48 12.385 6.463 13.719 6.427 15.053 C 8.099 15.025 9.77 15.026 11.442 15.056 L 11.403 11.096 C 9.761 11.079 8.119 11.064 6.477 11.051 Z M 11.391 9.856 L 11.355 6.062 C 10.508 6.052 9.66 6.04 8.813 6.024 L 6.37 5.963 C 6.422 7.266 6.455 8.569 6.47 9.873 C 8.11 9.825 9.751 9.819 11.391 9.856 Z" fill="rgb(197, 184, 223)" height="21.34968361606746px" id="fnu26aiQC" transform="translate(3.5 2.5)" width="17.44291014537199px"/><path d="M 4.522 3.23 C 5.78 1.997 8.155 1.905 12.588 2.095 C 12.578 1.405 12.711 0.729 13.67 0.333 C 15.282 -0.02 16.943 -0.093 18.58 0.117 C 20.297 0.526 20.476 1.954 20.416 3.582 C 21.5 5.276 21.393 9.338 21.127 19.39 L 21.038 22.8 C 21.912 22.818 22.633 22.843 23.142 22.875 C 23.358 22.889 23.524 23.071 23.518 23.288 C 23.513 23.504 23.338 23.678 23.122 23.682 C 15.546 24.112 7.952 24.106 0.378 23.664 C 0.167 23.661 -0.003 23.487 0 23.276 C 0.003 23.064 0.177 22.895 0.388 22.898 L 3.2 22.858 C 3.272 19.083 3.228 15.974 3.192 13.418 C 3.109 7.608 3.068 4.656 4.522 3.23 Z M 3.976 22.85 C 8.4 22.795 15.766 22.723 20.216 22.787 C 20.216 22.097 20.214 21.433 20.213 20.792 C 20.198 7.702 20.193 4.582 18.847 3.812 C 18.425 3.572 17.872 3.561 17.147 3.547 C 16.91 3.543 16.657 3.537 16.382 3.525 C 15.458 3.478 14.534 3.429 13.61 3.375 C 9.023 3.118 6.69 2.985 5.495 4.089 C 4.258 5.23 4.243 7.697 4.213 12.716 C 4.197 15.338 4.177 18.658 3.976 22.85 Z M 16.445 2.283 C 17.738 2.343 18.705 2.401 19.42 2.723 C 19.39 2.568 19.346 2.407 19.29 2.24 C 18.93 1.18 18.187 1.202 16.165 1.26 C 15.76 1.27 15.304 1.284 14.789 1.29 C 13.718 1.32 13.538 1.531 13.451 2.132 C 14.075 2.162 14.738 2.196 15.438 2.232 Z" fill="rgb(197, 184, 223)" height="23.999720020808233px" id="T0noVQH3N" width="23.51861246879796px"/></g></svg>)
Minimises time spent in clinic
As a portable device, Lily is designed to be used inside and outside the clinic: minimising time spent waiting in an infusion chair.
Timeline
We continue to develop our hair loss prevention program across both chemotherapy classes and new anti-cancer drugs.
Now
Proof of concept in several chemotherapy regimens in early patient studies.
Next
Completion of PREVAIL: a multi-center study into the prevention of chemotherapy-induced hair loss in the US.
Future
Commercial roll-out and expansion into ADCs.
LILY
Lily
Preventing hair loss caused by chemotherapy.
Lily is designed to help reduce chemotherapy related hair loss - supporting patients through one of treatment’s most visible and emotional side effects.
Portable, wearable device
Lily is a wearable headset device that's entirely portable - meaning patients aren't stuck in an infusion chair.
Designed for patient use
Paired with a simple control panel, Lily is designed for easy use by a patient, caregiver, or healthcare professional.
Comfortable, non-cooling therapy
Lily uses a non-cooling therapeutic approach that avoids cold-related pain on the scalp.
Minimises time spent in clinic
As a portable device, Lily is designed to be used inside and outside the clinic: minimising time spent waiting in an infusion chair.
Timeline
We continue to develop our hair loss prevention program across both chemotherapy classes and new anti-cancer drugs.
Now
Proof of concept in several chemotherapy regimens in early patient studies.
Next
Completion of PREVAIL: a multi-center study into the prevention of chemotherapy-induced hair loss in the US.
Future
Commercial roll-out and expansion into ADCs.
LILY
Lily
Preventing hair loss caused by chemotherapy.
Lily is designed to help reduce chemotherapy related hair loss - supporting patients through one of treatment’s most visible and emotional side effects.
Portable, wearable device
Lily is a wearable headset device that's entirely portable - meaning patients aren't stuck in an infusion chair.
Designed for patient use
Paired with a simple control panel, Lily is designed for easy use by a patient, caregiver, or healthcare professional.
Comfortable, non-cooling therapy
Lily uses a non-cooling therapeutic approach that avoids cold-related pain on the scalp.
Minimises time spent in clinic
As a portable device, Lily is designed to be used inside and outside the clinic: minimising time spent waiting in an infusion chair.
Timeline
We continue to develop our hair loss prevention program across both chemotherapy classes and new anti-cancer drugs.
Now
Proof of concept in several chemotherapy regimens in early patient studies.
Next
Completion of PREVAIL: a multi-center study into the prevention of chemotherapy-induced hair loss in the US.
Future
Commercial roll-out and expansion into ADCs.
LILY
Lily
Preventing hair loss caused by chemotherapy.
Portable, wearable device
Lily is a wearable headset device that's entirely portable - meaning patients aren't stuck in an infusion chair.
Designed for patient use
Paired with a simple control panel, Lily is designed for easy use by a patient, caregiver, or healthcare professional.
Comfortable, non-cooling therapy
Lily uses a non-cooling therapeutic approach that avoids cold-related pain on the scalp.
Minimises time spent in clinic
As a portable device, Lily is designed to be used inside and outside the clinic: minimising time spent waiting in an infusion chair.
Timeline
We continue to develop our hair loss prevention program across both chemotherapy classes and new anti-cancer drugs.
Now
Proof of concept in several chemotherapy regimens in early patient studies.
Next
Completion of PREVAIL: a multi-center study into the prevention of chemotherapy-induced hair loss in the US.
Future
Commercial roll-out and expansion into ADCs.
And we’re just getting started.
We’re moving fast to solve more of what’s missing in cancer care—from early-stage side effects to at-home monitoring and recovery support.It takes a team to change how cancer care works. If you're driven to build smarter, more human solutions,
And we’re just getting started.
We’re moving fast to solve more of what’s missing in cancer care—from early-stage side effects to at-home monitoring and recovery support.It takes a team to change how cancer care works. If you're driven to build smarter, more human solutions,
And we’re just getting started.
We’re moving fast to solve more of what’s missing in cancer care—from early-stage side effects to at-home monitoring and recovery support.It takes a team to change how cancer care works. If you're driven to build smarter, more human solutions,
Let’s improve cancer care, together.
If you're interested in piloting, collaborating, or simply learning more about how our technologies can fit your practice, we’d love to hear from you.
Let’s improve cancer care, together.
If you're interested in piloting, collaborating, or simply learning more about how our technologies can fit your practice, we’d love to hear from you.
Let’s improve cancer care, together.
If you're interested in piloting, collaborating, or simply learning more about how our technologies can fit your practice, we’d love to hear from you.
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
FUNDED BY
On Trial At
Featured In